| Dear Voornaam,
Welcome to your weekly Cancer Research UK Research Update email.
We have a call this week to take part in our cancer inequalities survey and help shape our strategy in this area. If you are thinking about where to go next to translate your research, there’s an online information session to learn more about Venture Builder Incubator, an upcoming entrepreneurial programme that we’ve partnered on with the University of Edinburgh. And looking ahead to this autumn’s committee and panel meeting, we’ve gathered links to our upcoming funding deadlines in September and October, which I hope you will find useful.
I do hope you are all well and looking forward to some time off over the summer.
Kind regards
Iain
Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons
Cancer Research UK |
|
|---|
|
|---|
|
|
September Funding & Research Opportunities |
|
|---|
|
|---|
|
|
October Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
 SHAPE OUR CANCER INEQUALITIES STRATEGY Cancer doesn’t affect everyone equally.
We want your input on how you consider cancer inequalities in your research design to help shape our strategy.
Please take our short (15-minute) survey by 15 August and share with your networks to help us reach a broad community of cancer researchers.
|
|
|---|
|  JOIN AN ONLINE INFO SESSION FOR VENTURE BUILDER INCUBATOR Join online next week (12:30PM BST, 12 August) to learn about this exciting programme for early-stage oncology-related ideas looking for a commercialisation path.
You’ll get an overview of how the Venture Builder Incubator can support you to create a data-driven, scientific-based start-up through its bespoke 16-week programme. |
|
|---|
|
|---|
|
|
RENEWED PARTNERSHIP TO CREATE VENTURES IN ONCOLOGY We’re expanding our alliance with Deep Science Ventures to generate more cutting-edge ventures across oncology.
This builds on our previous successful partnership which led to the formation of 3 new cancer therapeutics companies: Enedra Therapeutics, Stratosvir, and Neobe Therapeutics.
One of the new ventures will focus on deep reprofiling of the immune system within new specific immunotherapy-resistant contexts, whilst another, supported by the Children’s Tumor Foundation, will identify opportunities to create ventures and new approaches in neurofibromatosis. |
|
|---|
|
|---|
|
|
CALL FOR CRISPR SCREENING PROPOSALS If your research could benefit from state-of-the-art CRISPR technology, we’d love to work with you to progress your project. Our expert team can help you plan your project to give you the best opportunity for success.
We review and accept proposals every 2 months. The next deadline is 31 August.
Contact us to discuss your research ideas. |
|
|---|
|
|---|
|
|
A NEW EPISODE OF OUR CANCER RESEARCH MATTERS PODCAST IS OUT Give it a listen and hear Professor Sir Leszek Borysiewicz’s take on developing the HPV vaccine, the difficulties of navigating a research career and why we must embrace failure a bit. |
|
|---|
|
|---|
|
|
JOIN THE BRIGHTEST MINDS IN BRAIN TUMOUR RESEARCH If you’re interested in advancing understanding of what makes brain tumours tick and accelerating progress for patients, our Brain Tumour Conference – which takes place in London, 5–7 September – is the scientific meeting for you.
The latest speakers to join the line-up include Jony Kipnis, Washington University School of Medicine in St Louis; Giuseppe Battaglia, IBEC Barcelona; Steve Pollard, University of Edinburgh; and Misty Jenkins, Walter and Eliza Hall Institute of Medical Research, Australia.
Registration closes on 22 August. |
|
|---|
|
|---|
|
|
JOIN US IN AMSTERDAM FOR MAP 2022: 14–16 OCTOBER Secure your seat at the leading global meeting dedicated to precision oncology. Join key opinion leaders as they present their latest findings and explore topics including mechanisms driving tumour expansion, metastatic dissemination, and cross talk between malignancy, microenvironment and host.
Discounted early bird registration is available until 10 August. |
|
|---|
|
|---|
|
|
| | | London, UK 05 September 2022 |
|
|---|
|
|---|
| | | Cambridge, UK 20 September 2022 |
|
|---|
|
|---|
| | | London, UK 10 October 2022 |
|
|---|
|
|---|
| | | Amsterdam, Netherlands 14 October 2022 |
|
|---|
|
|---|
| | | Portland, Oregon, USA 18 October 2022 |
|
|---|
|
|---|
| | | Manchester, UK 15 November 2022 |
|
|---|
|
|---|
| | | East Sussex, UK 04 December 2022 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
